The BET Bromodomain inhibitor OTX015 affects pathogenetic pathways in pre-clinical B-cell tumor models and synergizes with targeted drugs. Homo sapiens
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA271952
下载链接
链接失效反馈官方服务：
资源简介：
assess the efficacy of OTX015, a BET Bromodomain inhibitor,with respect to various lymphoma models, and to characterize its mechanism of action Overall design: GEP analysis of 2 lymphoma cell lines with and without treatment with BET Inhibitor and 22 lymphoma cell lines without treatment (basal level).
创建时间：
2015-01-09
